Wilson A P, Prouse P J, Gumpel J M
Ann Rheum Dis. 1984 Jun;43(3):511-2. doi: 10.1136/ard.43.3.511.
A 63-year-old woman with seropositive rheumatoid arthritis was successfully treated with auranofin for 12 months. Heavy proteinuria then developed and the drug was stopped. However, the proteinuria apparently became worse. This was later recognised to be a spurious effect due to the introduction of tolmetin. Renal biopsy showed a type I membranous glomerulonephropathy.
一名63岁血清反应阳性类风湿性关节炎女性患者接受金诺芬治疗12个月，效果良好。随后出现大量蛋白尿，遂停用该药。然而，蛋白尿情况明显恶化。后来发现这是由于引入托美汀所致的假性效应。肾活检显示为I型膜性肾小球肾病。
